Literature DB >> 10701422

Determination of remifentanil in human heparinised whole blood by tandem mass spectrometry with short-column separation.

J Bender1, J van den Elshout, K Selinger, G Broeders, J Dankers, C van der Heiden.   

Abstract

For the use in pharmacokinetic studies, a fast and sensitive assay method was developed for the determination of remifentanil in human heparinised whole blood samples of 0.5 ml. The assay method is based on tandem mass spectrometry detection (LC-MS/MS). The limit of quantification is 0.1 ng/ml and linear up to 50 ng/ml. The precision, accuracy, recovery and applicability were found to be adequate for pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10701422     DOI: 10.1016/s0731-7085(99)00151-x

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Pharmacodynamics and arteriovenous difference of intravenous naloxone in healthy volunteers exposed to remifentanil.

Authors:  Ida Tylleskar; Arne Kristian Skulberg; Sissel Skarra; Turid Nilsen; Ola Dale
Journal:  Eur J Clin Pharmacol       Date:  2018-08-24       Impact factor: 2.953

2.  Population Pharmacokinetic Modelling for Estimation of Remifentanil Metabolic-Ratio Using Non-steady-State Concentrations under Rapidly Adaptive Dosing.

Authors:  Monica Simeoni; Chao Chen
Journal:  Pharm Res       Date:  2018-09-25       Impact factor: 4.200

3.  Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment.

Authors:  Des Breen; Alexander Wilmer; Andrew Bodenham; Vagn Bach; Jan Bonde; Paul Kessler; Sven Albrecht; Soraya Shaikh
Journal:  Crit Care       Date:  2003-11-21       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.